12.03.2010 • NewsLanxessleatherCoatings

Lanxess Invests In Leather Applications Technology

Lanxess said it is focusing on optimizing its top coat systems, especially those used for automotive leathers, and on expanding its share of the market. To this end, the Leather (LEA) business unit has invested in appropriate technologies and has now purchased a new type of roll coating machine for its Technology Center in Leverkusen. Michael Franken, head of Finishing in LEA's Product Development Application section, comments: "There is an increasing demand for new, environment-friendly processes for applying leather finishes and other coatings. We have therefore invested in product development so that we can play an active part in this trend." The Leather business unit's applications technologists can use the new roll coating machine to develop modern top coat formulations for their customers and help them with technical problems.

The new Gemata Topstar roll coating machine has specially developed rubber screen rollers for direct roll coating. This makes it possible to apply top coats more accurately and with virtually no wastage. In addition to cutting costs significantly, this method of application also improves the environmental balance of the leather production process compared with conventional spraying methods, where as much as 50% of the formulation may be wasted due to overspraying.

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read